Literature DB >> 9155848

Overview of nebuliser treatment.

M F Muers1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9155848      PMCID： PMC1765874          DOI： 10.1136/thx.52.2008.s25

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  11 in total

1.  Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output.

Authors:  J H Dennis; S C Stenton; J R Beach; A J Avery; E H Walters; D J Hendrick
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

2.  Disposable jet nebulizers. How reliable are they?

Authors:  G F Alvine; P Rodgers; K M Fitzsimmons; R C Ahrens
Journal:  Chest       Date:  1992-02       Impact factor: 9.410

3.  Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects.

Authors:  P M Tweeddale; F Alexander; G J McHardy
Journal:  Thorax       Date:  1987-07       Impact factor: 9.139

Review 4.  Solute permeability of the alveolar capillary barrier.

Authors:  M P Barrowcliffe; J G Jones
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

5.  Comparison of twenty three nebulizer/compressor combinations for domiciliary use.

Authors:  E C Smith; J Denyer; A H Kendrick
Journal:  Eur Respir J       Date:  1995-07       Impact factor: 16.671

6.  Terbutaline aerosol given through pear spacer in acute severe asthma.

Authors:  M D Morgan; B V Singh; M H Frame; S J Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-25

7.  Nebuhaler versus nebuliser in children with acute asthma.

Authors:  M Freelander; P P Van Asperen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

8.  Tc-99m-DTPA aerosol and radioactive gases compared as adjuncts to perfusion scintigraphy in patients with suspected pulmonary embolism.

Authors:  P O Alderson; D R Biello; A Gottschalk; P B Hoffer; S A Kroop; M E Lee; L Ramanna; B A Siegel; A D Waxman
Journal:  Radiology       Date:  1984-11       Impact factor: 11.105

9.  Assessment and provision of home nebulizers for chronic obstructive pulmonary disease (COPD) in the Yorkshire region of the U.K.

Authors:  H S Hosker; C Teale; M A Greenstone; M F Muers
Journal:  Respir Med       Date:  1995-01       Impact factor: 3.415

10.  Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.

Authors:  F W Dekker; A C Schrier; P J Sterk; J H Dijkman
Journal:  Thorax       Date:  1992-03       Impact factor: 9.139
View more
  3 in total

1.  Nebulizer therapy in cystic fibrosis: an overview.

Authors:  Nicola Collins
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

2.  A radiometric study of factors affecting drug output of jet nebulizers.

Authors:  G Mittal; N Kumar; H Rawat; M K Chopra; A Bhatnagar
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

3.  Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.

Authors:  Sebastian Schneeweiss; Malcolm Maclure; Bruce Carleton; Robert J Glynn; Jerry Avorn
Journal:  BMJ       Date:  2004-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.